Who is sponsoring NCT03701191?

NCT03701191 is sponsored by Marwa El Sayed Abbas Ahmed.

What drugs are being tested in NCT03701191?

Interventions in NCT03701191: Inverted periosteal pedicle flap.

What condition does NCT03701191 study?

NCT03701191 studies Gingival Recession.

Is NCT03701191 still recruiting?

NCT03701191 is currently status unknown. Last updated 13 January 2020.

Last reviewed 2020-01-13 · How we verify

NCT03701191: IPPF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Using Inverted Periosteal Pedicle Flap in Treatment of Gingival Recession

Status unknown NA Last updated 13 January 2020

What this trial tests

NA trial testing Inverted periosteal pedicle flap in Gingival Recession in 18 participants. Status unknown.

Timeline

25 January 2020

Primary endpoint
28 February 2020

28 August 2020

Quick facts

Lead sponsor	Marwa El Sayed Abbas Ahmed
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	18
Start date	25 January 2020
Primary completion	28 February 2020
Estimated completion	28 August 2020
Sites	1 location across Egypt

Drugs / interventions tested

Inverted periosteal pedicle flap

Conditions studied

Gingival Recession — all drugs for Gingival Recession →

Sponsor

Marwa El Sayed Abbas Ahmed

Who can join

Adults 20 to 65, any sex, with Gingival Recession. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Perioteum in the recession defect site will be used as an autogenous graft after raising a flap and the results will be compared with another group which will be treated by the gold standard ( coronally advanced flap with subepithelial connective tissue graft).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Postoperative discomfort following inverted periosteal pedicle graft versus subepithelial connective tissue graft for treating gingival recession RT1 & RT2: a randomized clinical trial.
Elsayed M, Salaheldin Darhous M, Gamal-AbdelNaser A, Reda Abdel Rahman A. · · 2026 · PMID 41569367 · DOI 10.1186/s40902-025-00499-0

Verify or expand the search:

Other recruiting trials for Gingival Recession

Currently open trials in the same condition.

NCT07513792 — The Impact of a 3D Imaging Tool on Reducing Gum Recession During Orthodontic Treatment With Aligners · NA · recruiting
NCT07437417 — A Novel Volume Stable Matrix for Gingival Recession Coverage at Teeth · NA · recruiting
NCT07158541 — Comparing TCAF and MTUN With Soft Tissue Grafting for Treating Single Recessions in the Premandible · NA · recruiting
NCT07104019 — Biofiller and Gingival Phenotype Thickening · NA · recruiting
NCT07291583 — Hyaluronic Acid With Connective Tissue Grafting for Gingival Recession · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03701191 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marwa El Sayed Abbas Ahmed
Last refreshed: 13 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03701191.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing